US2837574A
(en)
*
|
1956-03-15 |
1958-06-03 |
Olin Mathieson |
Chlorination of alcohols
|
US4223163A
(en)
*
|
1976-12-10 |
1980-09-16 |
The Procter & Gamble Company |
Process for making ethoxylated fatty alcohols with narrow polyethoxy chain distribution
|
US4366159A
(en)
*
|
1981-09-08 |
1982-12-28 |
Michael Richard Magruder |
Nalbuphine-narcotic analgesic composition and method of producing analgesia
|
US4587046A
(en)
*
|
1982-05-18 |
1986-05-06 |
The Regents Of The University Of California |
Drug-carrier conjugates
|
DE3675588D1
(en)
*
|
1985-06-19 |
1990-12-20 |
Ajinomoto Kk |
HAEMOGLOBIN TIED TO A POLY (ALKENYLENE OXIDE).
|
US4806556A
(en)
*
|
1985-12-12 |
1989-02-21 |
Regents Of The University Of Minnesota |
Gut-selective opiates
|
US4730048A
(en)
*
|
1985-12-12 |
1988-03-08 |
Regents Of The University Of Minnesota |
Gut-selective opiates
|
US4861781A
(en)
*
|
1986-03-07 |
1989-08-29 |
The University Of Chicago |
Quaternary derivatives of noroxymorphone which relieve nausea and emesis
|
US4719215A
(en)
*
|
1986-03-07 |
1988-01-12 |
University Of Chicago |
Quaternary derivatives of noroxymorphone which relieve nausea and emesis
|
US4801575A
(en)
*
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US5080891A
(en)
*
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
JPH01207320A
(en)
|
1988-02-15 |
1989-08-21 |
Daicel Chem Ind Ltd |
Production of aromatic polyether
|
US5102887A
(en)
*
|
1989-02-17 |
1992-04-07 |
Arch Development Corporation |
Method for reducing emesis and nausea induced by the administration of an emesis causing agent
|
DE69030829T2
(en)
*
|
1989-03-10 |
1998-01-15 |
Hoffmann La Roche |
Drugs for the detection of drugs
|
US5122614A
(en)
*
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
US5324844A
(en)
*
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
JPH0383914A
(en)
*
|
1989-08-18 |
1991-04-09 |
W R Grace & Co |
Drug carrier
|
DE3937797A1
(en)
*
|
1989-11-14 |
1991-05-16 |
Basf Ag |
METHOD FOR PRODUCING POLYETHERGLYCOLES
|
US5130126A
(en)
*
|
1990-07-09 |
1992-07-14 |
Nippon Oil & Fats Co., Ltd. |
Polymer-drug conjugate and a method of producing it
|
IE912365A1
(en)
*
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
JP2829794B2
(en)
*
|
1991-02-08 |
1998-12-02 |
エスエス製薬 株式会社 |
Orally administered pranoprofen formulation for sustained release
|
US5250542A
(en)
*
|
1991-03-29 |
1993-10-05 |
Eli Lilly And Company |
Peripherally selective piperidine carboxylate opioid antagonists
|
US5270328A
(en)
*
|
1991-03-29 |
1993-12-14 |
Eli Lilly And Company |
Peripherally selective piperidine opioid antagonists
|
US5159081A
(en)
*
|
1991-03-29 |
1992-10-27 |
Eli Lilly And Company |
Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
|
AU4406793A
(en)
|
1992-06-04 |
1993-12-30 |
Clover Consolidated, Limited |
Water-soluble polymeric carriers for drug delivery
|
GB9316895D0
(en)
*
|
1993-08-13 |
1993-09-29 |
Guy S And St Thomas Hospitals |
Hepatoselective insulin analogues
|
EP0599303A3
(en)
*
|
1992-11-27 |
1998-07-29 |
Takeda Chemical Industries, Ltd. |
Peptide conjugate
|
US5298643A
(en)
*
|
1992-12-22 |
1994-03-29 |
Enzon, Inc. |
Aryl imidate activated polyalkylene oxides
|
US5321095A
(en)
*
|
1993-02-02 |
1994-06-14 |
Enzon, Inc. |
Azlactone activated polyalkylene oxides
|
US5298410A
(en)
*
|
1993-02-25 |
1994-03-29 |
Sterling Winthrop Inc. |
Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life
|
DE69413955T2
(en)
|
1993-03-17 |
1999-04-01 |
Minnesota Mining And Mfg. Co., Saint Paul, Minn. |
AEROSOL COMPOSITION CONTAINING A DERIVATIVE DERIVATIVE FROM ESTER, AMID OR MERCAPTOESTER
|
AU7113594A
(en)
*
|
1993-06-21 |
1995-01-17 |
Enzon, Inc. |
Site specific synthesis of conjugated peptides
|
US5643575A
(en)
*
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5434171A
(en)
*
|
1993-12-08 |
1995-07-18 |
Eli Lilly And Company |
Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
|
US5469478A
(en)
*
|
1994-07-15 |
1995-11-21 |
National Semiconductor Corporation |
Digital phase lock loop for jitter filtering and frequency offset compensation
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
US5670477A
(en)
*
|
1995-04-20 |
1997-09-23 |
Joseph F. Poduslo |
Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents
|
NZ322686A
(en)
|
1995-10-19 |
2000-01-28 |
Univ Washington |
Discrete-length polyethene glycols
|
US5639705A
(en)
*
|
1996-01-19 |
1997-06-17 |
Arco Chemical Technology, L.P. |
Double metal cyanide catalysts and methods for making them
|
EP0914097B1
(en)
*
|
1996-03-12 |
2002-01-16 |
Alza Corporation |
Composition and dosage form comprising opioid antagonist
|
US5856369A
(en)
|
1996-07-30 |
1999-01-05 |
Osi Specialties, Inc. |
Polyethers and polysiloxane copolymers manufactured with double metal cyanide catalysts
|
DE19632440A1
(en)
|
1996-08-12 |
1998-02-19 |
Basf Ag |
Easily prepared and separated catalyst giving pure alkoxylation product with narrow molecular weight distribution
|
US6214966B1
(en)
*
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
US6258351B1
(en)
*
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
DE19651551C2
(en)
*
|
1996-12-11 |
2000-02-03 |
Klinge Co Chem Pharm Fab |
Opioid antagonist-containing galenic formulation
|
US6011008A
(en)
*
|
1997-01-08 |
2000-01-04 |
Yissum Research Developement Company Of The Hebrew University Of Jerusalem |
Conjugates of biologically active substances
|
GB9703044D0
(en)
|
1997-02-14 |
1997-04-02 |
Glaxo Group Ltd |
Phenyl xanthine esters and amides
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US5972954A
(en)
*
|
1997-11-03 |
1999-10-26 |
Arch Development Corporation |
Use of methylnaltrexone and related compounds
|
US6163313A
(en)
|
1997-12-12 |
2000-12-19 |
Aroyan; James L. |
Touch sensitive screen and method
|
EP1037649B1
(en)
|
1997-12-17 |
2009-09-30 |
Enzon, Inc. |
Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
|
US6624142B2
(en)
|
1997-12-30 |
2003-09-23 |
Enzon, Inc. |
Trimethyl lock based tetrapartate prodrugs
|
PT1061954E
(en)
*
|
1998-03-12 |
2004-10-29 |
Nektar Therapeutics Al Corp |
POLY (ETHYLENE GLYCOL) DERIVATIVES WITH NEXT REACTIVE GROUPS
|
EP1068181B1
(en)
*
|
1998-03-30 |
2003-05-07 |
Lg Chemical Limited |
Polyethoxylated retinamide derivatives and process for preparing the same
|
US6703381B1
(en)
*
|
1998-08-14 |
2004-03-09 |
Nobex Corporation |
Methods for delivery therapeutic compounds across the blood-brain barrier
|
EP0995757A3
(en)
|
1998-08-26 |
2002-05-22 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bivalent inhibitors of the proteasome
|
US7060708B2
(en)
|
1999-03-10 |
2006-06-13 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
KR100345214B1
(en)
|
1999-08-17 |
2002-07-25 |
이강춘 |
The nasal transmucosal delivery of peptides conjugated with biocompatible polymers
|
US6669951B2
(en)
*
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
US6380405B1
(en)
*
|
1999-09-13 |
2002-04-30 |
Nobex Corporation |
Taxane prodrugs
|
US6713454B1
(en)
*
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
US6541508B2
(en)
*
|
1999-09-13 |
2003-04-01 |
Nobex Corporation |
Taxane prodrugs
|
US6451806B2
(en)
*
|
1999-09-29 |
2002-09-17 |
Adolor Corporation |
Methods and compositions involving opioids and antagonists thereof
|
NZ518401A
(en)
*
|
1999-10-29 |
2004-01-30 |
Nektar Therapeutics |
Dry powder compositions having improved dispersivity
|
DE60026073T2
(en)
*
|
1999-12-22 |
2006-09-28 |
Nektar Therapeutics Al, Corp., Huntsville |
STERRICOUS DERIVATIVES OF WATER-SOLUBLE POLYMERS
|
US6413507B1
(en)
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
AU2001257577A1
(en)
*
|
2000-02-28 |
2001-09-03 |
Shearwater Corporation |
Water-soluble polymer conjugates of artelinic acid
|
ATE448194T1
(en)
*
|
2000-08-29 |
2009-11-15 |
Biocon Ltd |
USE OF A PHARMACEUTICAL COMPOSITION CONTAINING A PARA-AMINOPHENYLACETIC ACID DERIVATIVE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
|
US7118737B2
(en)
*
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
US7829074B2
(en)
*
|
2001-10-18 |
2010-11-09 |
Nektar Therapeutics |
Hydroxypatite-targeting poly(ethylene glycol) and related polymers
|
US20020182172A1
(en)
*
|
2000-11-30 |
2002-12-05 |
Shearwater Corporation |
Water-soluble polymer conjugates of triazine derivatives
|
EP1349855B1
(en)
*
|
2000-12-22 |
2006-08-23 |
Smithkline Beecham Plc |
5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt
|
DE60223499T2
(en)
|
2001-02-20 |
2008-10-16 |
Enzon, Inc. |
TERMINAL BRANCHED, POLYMER LEFT AND THESE POLYMERS CONJUGATED
|
US20020169125A1
(en)
*
|
2001-03-21 |
2002-11-14 |
Cell Therapeutics, Inc. |
Recombinant production of polyanionic polymers and uses thereof
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6756354B2
(en)
*
|
2001-09-05 |
2004-06-29 |
Deanna Jean Nelson |
Therapeutic compositions containing oligo (ethylene glycol)-terminated 1,2-dithiolanes and their conjugates
|
MXPA04003597A
(en)
|
2001-10-18 |
2004-07-30 |
Nektar Therapeutics Al Corp |
Polymer conjugates of opioid antagonists.
|
KR20050040832A
(en)
|
2001-10-29 |
2005-05-03 |
넥타르 테라퓨틱스 에이엘, 코포레이션 |
Polymer conjugates of protein kinase c inhibitors
|
JP2005507934A
(en)
*
|
2001-10-30 |
2005-03-24 |
ネクター セラピューティックス エイエル,コーポレイション |
Water-soluble polymer conjugate of retinoic acid
|
CA2822457C
(en)
|
2001-12-14 |
2016-03-08 |
The University Of Wyoming |
Methods and compositions for controlled resease of drugs
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
US20040152769A1
(en)
|
2002-11-09 |
2004-08-05 |
Ekwuribe Nnochiri Nkem |
Modified carbamate-containing prodrugs and methods of synthesizing same
|
WO2004082620A2
(en)
|
2003-03-13 |
2004-09-30 |
Controlled Chemicals, Inc. |
Oxycodone conjugates with lower the abuse potential and extended duration of action
|
CA2528465A1
(en)
*
|
2003-06-09 |
2005-01-20 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of growth hormone
|
GB0317815D0
(en)
|
2003-07-30 |
2003-09-03 |
Amersham Health As |
Imaging agents
|
EP1651163B1
(en)
|
2003-08-01 |
2015-03-04 |
Biocon Limited |
Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
|
EP1653924A4
(en)
|
2003-08-12 |
2009-09-09 |
Middlebrook Pharmaceuticals In |
Antibiotic product, use and formulation thereof
|
EP1694347B1
(en)
|
2003-11-24 |
2013-11-20 |
BioGeneriX AG |
Glycopegylated erythropoietin
|
US7786133B2
(en)
*
|
2003-12-16 |
2010-08-31 |
Nektar Therapeutics |
Chemically modified small molecules
|
US20060182692A1
(en)
|
2003-12-16 |
2006-08-17 |
Fishburn C S |
Chemically modified small molecules
|
ES2390286T3
(en)
*
|
2005-12-16 |
2012-11-08 |
Nektar Therapeutics |
GLP-1 polymer conjugates
|
JP5586223B2
(en)
|
2006-04-21 |
2014-09-10 |
ネクター セラピューティクス |
Stereoselective reduction of morphinone.
|
EP2341942A1
(en)
*
|
2008-09-19 |
2011-07-13 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|